PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Institute of Health Data Science at Peking University, Beijing, 100191, China.\', \'Peking University Advanced Institute of Information Technology, Hangzhou, 311215, China.\', \'Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.\', \'Department of Clinical Nutrition, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.\', \'Taikang Tongji (Wuhan) Hospital, Wuhan, 430050, China.\', \'Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, 100034, China.\', \'Peking-Tsinghua Center for Life Sciences, Beijing, 100871, China.\', \'First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.\', \'National Institute of Health Data Science at Peking University, Beijing, 100191, China. zhanglx@bjmu.edu.cn.\', \'Peking University Advanced Institute of Information Technology, Hangzhou, 311215, China. zhanglx@bjmu.edu.cn.\', \'Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, 100034, China. zhanglx@bjmu.edu.cn.\', \'Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital; Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health; Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, 100191, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11684-021-0850-9
?:hasPublicationType
?:journal
  • Frontiers of medicine
is ?:pmid of
?:pmid
?:pmid
  • 34241787
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.913
?:rankingScore_hIndex
  • 25
is ?:relation_isRelatedTo_publication of
?:title
  • Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34241787>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34241787>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all